Abbvie Contract MFG

  Why Aseptic Fill Finish is Essential to the Pharmaceutical Industry An aseptic fill finish , also known as sterile filling of drugs, is the last and one of the most challenging stages in the drug creation processes. This process is so complex because it requires careful planning, thoroughly trained workers, and specialized facilities/ equipment to pull it off. It also requires close coordination and complex interactions between the persons operating the systems, sterilized products, clean room, and sterilized filling equipment. This process of fill finish manufacturing is a process that relies significantly on a perfect technique, and slight errors can have a significant impact on the end-users. Considering that these sterile drugs are to be used on already compromised patients, it is important that they relieve and not further complicate the situation. Many complex biochemical, pharmaceutical, and biotechnology drugs products wouldn't be able to undergo terminal sterilization ri...

  An Overview of Aseptic FillFinish Aseptic fillfinish first hit the market in the 1920s. For a drug, this can be considered relatively recent, and it was created out of the need to meet the needs of injectables and large scale manufacturing of blood and plasma during WWII.  The world needed certain drugs that couldn't undergo the rigors of the previously used filtration processes. Plasma, for example, did and still has significant use in the hospital, and previously had to undergo a post-fill filtration of low heat treatment.  This pasteurization process wasn’t effective as it didn’t sterilize the plasma but only reduced the chances of getting contaminated by fungi. Back then, anti-fungal reagents may also have been added to parental drugs to reduces their chances of contamination.  The world saw her first glimpse of what we now called aseptic fill-finish in 1981. That was when the Parental Drug Association published its Aseptic Validation Technical to improve the ...

The Demand for Medicine Fill Finish Operations Error-free fill-finish operations in pharmaceutical and biopharmaceutical manufacturing are crucial to making sure of patient safety. The growing diversity of biologic drugs also has a part in products targeted for parenteral delivery in the demand for aseptic fill-finish operations. However, to effectively meet this growing demand for fill-finish services requires specialized expertise. This includes appropriate equipment and innovations in both emerging technology and business models. Fill-Finish Manufacturing In pharmaceutical manufacturing, fill-finish operations are critical. They are the last step before a product is packaged and delivered to the patient. A drug product is highly valuable at this step. It has been through labor- and cost-intensive production stages. Stages like upstream processing, cell culture or fermentation, and downstream purification. Failures within the integrity of the fill-finish stage can introduc...

  Fill Finish for Biologics Fill-Finish for biologics is an industrial activity, focused on efficient product formulation and packaging. Fill-Finish, far more than bioprocessing, involves complex engineering — filling, fluid, and solid dispensing and sealing systems. Most innovations in bioprocessing, including the adoption of single-use/disposable equipment and increases in product yield/output, haven't moved into Fill-Finish operations (with some exceptions, such as single-use storage bags, tubing, and filling tips). Fill-finish professionals tend to more be engineers instead of scientists. However, Fill-Finish was among the primary areas to adopt silicone and other single-use tubing and manifolds in situ of chrome steel piping. Broader issues in bioprocessing, like the difficulties with downstream purification processes maintaining with increased upstream yields, generally don't affect Fill-Finish operations, which rarely are the main bottlenecks in product manufacture. Mul...

The Growing Fill Finish Manufacturing Industry The Fill-Finish industry has been growing at the same rate as overall biopharma manufacturing.  With almost three decades of experience with aseptic fill filling and lyophilization, Abbvie Contract Manufacturing has a broad range of knowledge and expertise in biopharmaceuticals. Fill-Finish stays very critical to biopharma manufacture. Its operations are mostly performed by CMOs, which dominate what has become a unique Fill-Finish CMO-based industry. The products validate the ongoing trend seen in bioprocessing of manufacturing being produced at a smaller scale, whether due to less product demand or higher yields. Abbvie Contract Manufacturing services cover Cell line development, Fermentation biotechnology, now-how and proven quality, regulatory, and operational network to help you achieve your milestones of cGMP manufacturing, Process optimization, Analytical characterization, and Validation. We are your complete and best choice for...

Drug and Medicine Fill Finish AbbVie Contract Manufacturing aims to increase the global pharmaceutical capability through its fully integrated production facility that offers fill finish services, process development, and drug substance manufacturing. We offer a range of solutions in biologics development and manufacturing. Our facility supplies biopharmaceutical products to meet growing manufacturing demands from global pharmaceutical companies. AbbVie Pharmaceutical Contract Manufacturing offers advanced cGMP facilities providing clinical and commercial products based on mammalian cell culture.  All processes are cGMP-compliant and follow the guidelines of the U.S. FDA, EMA, and local authorities. Our dedication to quality and optimal services is visible in everything we do, from small-scale clinical trials to large-scale commercial manufacturing. Drug Fill Finish Drug producers need to constantly deliver on all these fronts and more, without undermining speed-to-market, to mana...

AbbVie Pharmaceutical Fill Finish Manufacturing AbbVie Pharmaceutical Fill Finish Manufacturing offers a range of solutions in biologics development and manufacturing. We aim to improve the global pharmaceutical capability through a fully integrated production facility that offers fill and finish services, drug substance development and contract manufacturing at one location. AbbVie’s new aseptic fill/finish vial line is situated in Sligo, Ireland. This state-of-the-art line facility supplies biopharmaceutical products to meet growing manufacturing demands from global pharmaceutical companies. We offer services to clients throughout the year, including small batches for clinical trials to large-scale shipments for commercial manufacture. AbbVie Medicine Fill Finish AbbVie Pharmaceutical offers medicine fill-finish with advanced cGMP facilities - providing clinical and commercial products based on mammalian cell culture. All processes are cGMP-compliant and follow the guidelines of the...